Project Grant K12TR005992
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $558,631 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to develop and deliver predoctoral training in clinical and translational research and translational science. The University of Pittsburgh's Institute for Clinical Research Education (ICRE), in collaboration with the Clinical and Translational Science Institute (CTSI), will train the next...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $502,465 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral T32 training initiative in clinical and translational research. The award funds the University of Pittsburgh Institute for Clinical Research Education (ICRE) to deliver comprehensive postdoctoral fellowship training and career development programs designed to equip...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded the University of Pittsburgh a cooperative agreement totaling $10,192,245 on July 15, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). The University of Pittsburgh Clinical and Translational Science Institute will operate as a learning research system to systematically identify and disseminate generalizable methods that accelerate translational research...
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $1.62 million on August 1, 2026, under the NCATS program (CFDA 93.350) to operate a mentored research career development program in clinical and translational science. The University of Pennsylvania will identify, recruit, train, and retain nine early-career scientists across varied educational backgrounds and professional experiences, guiding them toward scientific independence and leadership in...
- The National Center for Advancing Translational Sciences awarded University of Massachusetts Medical School $949,994 on April 1, 2026, under the NCATS program (CFDA 93.350) to support a K12 career development program in translational science. The award funds the development and mentorship of junior faculty scholars pursuing careers in translational science. The program will support four NCATS-funded scholars at any given time, forming the core of a nine-scholar umbrella initiative that...
- The National Center for Advancing Translational Sciences awarded Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) $725,350 on August 13, 2026, under the NCATS K12 Program (CFDA 93.350) to support early-career faculty development in translational science. The award funds a structured 2–3 year intensive career development and research training program for 3 cohorts of early-career faculty scholars (3 scholars per cohort), organized around three pillars:...
- The National Center for Advancing Translational Sciences awarded New York University $6.28 million on April 15, 2026, under the CTSA K12 Program (CFDA 93.350) to train early-stage clinical and translational researchers through career development at the NYU Clinical Translational Science Institute. The award funds a structured training program composed of didactic courses, experiential learning, and individualized leadership coaching. Scholars receive mentorship from at least two science mentors,...
- The National Institutes of Health National Center for Advancing Translational Sciences awarded the University of Pennsylvania $532,701 on July 6, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in clinical and translational science. The award funds the CTSA Postdoctoral T32 at Penn, which trains clinical and translational science investigators to move scientific discoveries from the laboratory into clinical...
- The National Center for Advancing Translational Sciences awarded Georgetown University $752,548 on September 1, 2026, under the CTSA K12 Program (CFDA 93.350) to support clinical and translational science training and career development for early-stage investigators. Georgetown University operates the K12 program as part of the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a partnership that includes Howard University, MedStar Health Research...
- The National Center for Advancing Translational Sciences awarded the University of California Irvine $1.512 million on March 15, 2026, under the NCATS K12 Project Grant program (CFDA 93.350) to establish a mentored career development core for clinical translational science and research. The program supports the training of four K12 scholars per year through structured mentorship, individual development planning, and scholar-mentor alignment oversight. UCI operates an affiliated scholars...
The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $1,025,770 on August 1, 2026, under the NCATS K12 Program (CFDA 93.350) to develop the next generation of clinical and translational research experts and translational scientists. The University of Pittsburgh will train scholars in translational science and domain-specific skills required for careers as clinical and translational researchers and translational scientists, provide cross-disciplinary career development support in leadership, management, and network-building, and deliver mentored research experiences complemented with individualized training and grant-writing instruction. The program builds on the university's KL2 Scholars Program, now in its 21st year, which emphasizes multidisciplinary mentoring and career development for medical and graduate students, postdoctoral fellows, and faculty members. The overarching aim is to prepare scholars to overcome barriers in the clinical and translational research pathway and accelerate delivery of treatments to patients. The award has a period of performance from August 1, 2026, through May 31, 2031, with place of performance in Pittsburgh, Pennsylvania. The NCATS K12 Program supports institutional career development awards that train investigators to conduct clinical and translational research, addressing bottlenecks in the translational pipeline to speed delivery of drugs, diagnostics, and medical devices to patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.0m | 7/29/26 |